Switzerland Approves Pfizer COVID-19 Vaccine...First Case Through Standard Procedure
[Asia Economy Reporter Park Jihwan] Swiss authorities approved the use of Pfizer's COVID-19 vaccine on the 19th (local time).
The Swissmedic, the pharmaceutical regulatory authority, stated, "After thoroughly reviewing the available information, it was concluded that the Pfizer-BioNTech COVID-19 vaccine is safe and its benefits outweigh the risks."
They also added, "This represents the world's first approval through the ordinary procedure."
Hot Picks Today
Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- Is It the “8,000-Point Curse”? KOSPI Drops to 7,400 After Brief Surge; KOSDAQ Falls 5%
- "Multi-Million Won Bonuses, Life Is Sweet"—Even Employee Reactions... SK hynix Overtakes Samsung to Claim No. 1 Spot
- "Gave in to the Momentary Temptation": Japanese Police Official Dismissed After Stealing 100 Million Won Next to Body
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
Previously, the UK, the US, Bahrain, Mexico, and others had approved the emergency use of the Pfizer-BioNTech vaccine.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.